AB-11-MO96_10uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=10uM, 3-Chloro-6-piperazin-1-yl-11H-dibenzo[b,e]azepine, Dopamine D2 Agonists;Muscarinic M1 Agonists;5-HT2A Inverse Agonists targeting CHRM1, DRD2, HTR2A (Novartis, 11289917)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/11289917
Similar Terms
Downloads & Tools

Genes

15 genes differentially expressed following the AB-11-MO96_10uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
PPDPF pancreatic progenitor cell differentiation and proliferation factor 0.728913
RPL31 ribosomal protein L31 0.710476
FDFT1 farnesyl-diphosphate farnesyltransferase 1 0.701593
SH3D19 SH3 domain containing 19 0.650372
TMSB10 thymosin beta 10 0.308179
RPS18 ribosomal protein S18 0.280259
BLVRB biliverdin reductase B 0.275069
FBXW5 F-box and WD repeat domain containing 5 0.259608
FTL ferritin, light polypeptide 0.23333
PRDX5 peroxiredoxin 5 0.220386

decreased expression

Symbol Name Standardized Value
COTL1 coactosin-like F-actin binding protein 1 -0.75172
TAGLN transgelin -0.309614
HRNR hornerin -0.275069
EMC10 ER membrane protein complex subunit 10 -0.269791
JPT1 Jupiter microtubule associated homolog 1 -0.200975